The Inhalable Drugs Market is experiencing significant growth, driven by several key factors. One of the primary drivers is the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. As the global population continues to age and environmental factors such as air pollution worsen, the incidence of respiratory ailments rises, creating a substantial demand for inhalable drugs for management and treatment. Moreover, the ... Read more
